UPSC NDA 1 registration 2025 ends tomorrow; exam on April 13 Alivia Mukherjee . 30 Dec 2024 UPSC NDA, NA Results 2024: List of 641 recommended candidates, mark sheet out at upsc.gov.in Anu Parthiban . 06 Nov 2024 UPSC NDA, NA 1 final result 2024 out; 641 candidates qualify, Armaanpree...
(iii) Admission to the above courses will be made on the results of the written examination to be conducted by the Commission followed by intelligence and personality test by the Services Selection Board of candidates who qualify in the written examination . Education Qualification: (i) For Army ...
[2]Yongfeng Yu(Shanghai, CN),et al.478O - Updated results of oral PD-L1 inhibitor ABSK043 in advanced solid tumor patients (pts) from a phase I study.2024 ESMO Asia. Abs 478O. [3]Yi-Long Wu(Guangzhou, CN...
For this reason, individuals can request a report to be prepared according to which scale they can get a higher rate from, which results in more than one report being issued in more than one center in practice. Such demands lead to a loss of credibility in for...
泽沃基奥仑赛是一款自体BCMA靶向的CAR-T细胞产品。2024年3月1日,国家药品监督管理局批准了其新药上市申请,用于复发或难治性多发性骨髓瘤的治疗。泽沃基奥仑赛意义重大,它是我国第五款上市的CAR-T细胞产品,通顺也是国内第二款靶向BCM...
EL MONTE, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) --GigaCloud Technology Inc(Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that it will report its unaudited financial results for the ...
Results: Of the participants, 52.1% (n=110) were female. The average age was 59.8卤13.3 years (min:25-max:80). Hypertension was diagnosed in 47.4%, atherosclerotic heart disease in 27%, hyperlipidemia in 23.7%, obesity in 22.7%, and cerebrovascular disease in 2.4%....
2024年3月12日,新华社全文播发李强总理代表国务院在十四届全国人大二次会议上所作的《政府工作报告》。报告中英文对照如下:政府工作报告——2024年3月5日在第十四届全国人民代表大会第二次会议上国务院总理 李强REPORT ON THE WORK OF THE GOVERNMENTDelivered at the...
Conclusion: These results indicate that epibatidine administration before ischemia has a protective effect on kidney in renal I/R injury induced rats.Brklüce, AyeEmmez, Gkennan, GzdeGülbahar, zlemKilicoglu, Sibel SerinGültekin, Mehmet Serdar...
依沃西单抗(Ivonescimab,AK112,依沃西注射液,依达方®)是一款人源化IgG1-ScFv结构双特异性抗体新药,同时针对VEGF和PD-1双靶点。 2024年5月24日,获中国国家药品监督管理局(NMPA)批准上市,用于经EGFR-TKI(表皮生长因子受体+酪氨酸激...